Table 1 Participants’ demographic and clinical profile, predictors, and outcomes (N = 151)
Demographic and clinical profile | mean (SD) / n (%) |
|---|---|
Age, mean year (SD) | 89.8 (3.6) |
Gender, n (%) | |
 Male | 55 (36.2) |
 Female | 96 (63.6) |
Marital status, n (%) | |
 Unmarried | 2 (1.3) |
 Married | 56 (36.8) |
 Widowed/divorced/separated | 93 (61.6) |
Educational attainment, n (%) | |
 Tertiary | 2 (1.3) |
 Secondary | 13 (8.6) |
 Primary | 63 (41.7) |
 Nil | 73 (48.3) |
Living condition, n (%) | |
 Living alone | 63 (41.7) |
 Living with family/domestic helper/friends | 88 (57.9) |
Chronic diseases, n (%) | |
 Diabetes Mellitus | 21 (13.9) |
 Heart diseases | 26 (17.2) |
 Osteoarthritis | 8 (5.3) |
 Cancer | 5 (3.3) |
 Hypertension | 108 (71.5) |
BMI, mean (SD) | 23.6 (3.7) |
BMI, n (%) | |
 Underweight (BMI < 18.5) | 8 (5.3) |
 Normal (BMI = 18.5–22.9) | 61 (40.4) |
 Overweight (BMI = 23–25) | 36 (23.8) |
 Obese (BMI > 25) | 46 (30.5) |
Cognitive function | |
 AMT, mean (SD) | 8.5 (1.3) |
Predictors | Â |
MVPA | |
 Minutes per week, mean (SD) | 181.3 (202.5) |
Life-space mobility score, mean (SD) | 1035.3 (141.7) |
Time spent in each life-space zone, mean % (SD) | |
 Zone 1 | 84.0 (13.0) |
 Zone 2 | 12.6 (12.0) |
 Zone 3 | 1.2 (2.4) |
 Zone 4 | 2.3 (4.6) |
Outcomes | Â |
Sarcopenia (SARC-F), mean (SD) | 2.1 (2.1) |
Sarcopenia (SARC-F ≥ 4), n (%) | |
 Yes | 37 (24.5) |
 No | 114 (75.5) |